Know your World in Just 60 Words!
Read news in 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2021-11-24 11:17:46

Two doses of Covaxin, also known as BBV152 are only 50% effective against symptomatic coronavirus disease, the first real-world assessment of India's indigenous COVID-19 vaccine published in The Lancet Infectious Diseases journal showed. For the study, a total of 2,714 symptomatic hospital workers at the All India Institute of Medical Sciences (AIIMS) here, who were primarily offered Covaxin were assessed, from April 15 May 15.

Covid 19 Update

Headlines

Good News

politics

India

World

Copyright © 2019 Newz Viewz | Created by Communicators and Developed by Seawind Solution Pvt. Ltd.